Introducing 3-[(1R,2S)-2-Amino-1-Hydroxypropyl]Phenol 2,3-Dihydroxybutanedioate (1:1): Insight from Manufacturing

The Substance in Focus: Structure and Formulation

If you stand in the middle of a production line at a chemical manufacturing plant, daily familiarity with the characteristics of materials shapes your view on what matters most. The compound 3-[(1R,2S)-2-Amino-1-Hydroxypropyl]Phenol 2,3-Dihydroxybutanedioate (1:1) emerges in our catalog for reasons grounded in its structure and consistency during formulation and synthesis. With the molecular formula of C9H13NO2·C4H6O6, this substance is the tartrate salt form of a phenolic amino alcohol, representing both stability and preferred bioavailability for downstream applications, particularly in pharmaceutical and fine chemical contexts.

Years on the production floor teach how certain isomers present different handling characteristics, both in solubility and reactivity, and here, the (1R,2S) stereochemistry directly impacts biological interaction while preserving purity during scaling. Our synthesis emphasizes precise chiral control—not merely from habit, but from hard-won experience after batches lost to inconsistency. Analytical results show how tartrate pairing assists not just in crystallization, but in safeguarding the functional groups during long-term storage and transport, reducing the risk of hydrolysis under ambient temperatures common in bulk shipping.

From Raw Material to Final Use: The Value Chain Perspective

People sometimes overlook the transformation journey, and years in chemical manufacturing have underscored that process integrity influences every downstream benefit. During the conversion from phenolic intermediates, batch records reveal how temperature ramps and solvent selection determine yield and color. Small deviations lead to off-spec product or residual solvent inclusion—the sorts of headaches that follow you when a batch doesn’t meet rigorous purity specs.

Customers working with catecholamine analogs, pharmacological chiral building blocks, or specialized resin modifiers need chemistry they can count on—batch after batch, year to year. Many products pass through multiple hands on the journey to the end-user, but manufacturing at the source provides an inside look at crystalline form, particle size distribution, and solvent residue content, all of which create subtle differences in how a chemical performs in applied research or formulation.

Usage: More Than a Reagent

In the market, you’ll find many phenol derivatives serving as synthetic intermediates, but firsthand exposure reveals where this one carves its own path. This compound’s hydroxypropyl and amino positioning, plus its tartrate partner, give it distinct solubility. It dissolves smoothly in polar media, letting medicinal chemists handle and process the substance without fuss over precipitation or foam.

Pharmaceutical developers who build beta-blockers, adrenergic antagonists, or diagnostic reagents turn to chiral phenolic derivatives because slight changes in stereochemistry and salt form influence binding, uptake, and ultimately clinical results. The hours spent preparing batches for compounding teach how subtle shifts in moisture content or residual acidity change batch reactivity—lessons that drive improvements in our own procedures.

Bulk customers for dye synthesis, analytical research, or polymers provide feedback grounded in actual process economics; they want compounds that dissolve fast, clear easily, and introduce no byproduct contamination. You find the value in designing crystal habit via selective recrystallization, so the product flows evenly without caking or requiring reprocessing. It comes from direct experience: a project lost because of stubborn agglomeration turns into an improved granulation step the next round. These are changes driven not by catalog claims, but by running the lines, tuning the dryers, and watching the product pouring out the chute.

What Sets This Compound Apart?

Dissecting the practical differences between this tartrate salt and other phenolic intermediates, one ongoing reality is that not all derivatives behave the same in real-world handling. Many competitors offer the free base form or alternative salt compositions such as hydrochloride or sulfate; those have their uses, but tartrate brings a few tangible benefits customers see reflected back in their own QC reports.

For instance, it’s not just about the melting point or the moisture uptake chart. A tartrate format helps with shelf stability, an underrated advantage when shipping in humid climates. We’ve run storage stability assays spanning months, and visible degradation appeared much slower relative to the free base or other acid partner salts. That sort of predictability is essential for clients with long supply chains, or for contract manufacturers managing inventory buffers to avoid recalibration or excess retesting.

Handling differences show up during wet granulation and milling steps, too. Our operators log granule shape, particle softness, and pack density after each dryer run, and several reports over the years showed tartrate delivering less dust formation—good for plant safety, but also for minimizing contamination risks in next-step synthesis. With other salts, breakdown products during tableting or blending sometimes introduce off-odors or discoloration detectable even at parts-per-million levels, commonly flagged by QA teams. We saw fewer events flagged when switching to tartrate forms, giving both our operators and the QA groups on the customer’s end fewer reasons to pause runs.

Specification Details from the Manufacturing Floor

In the real world of chemical processing, specification means more than a list of values on a COA: it means consistency, confidence, and fewer returns. When you do most syntheses on kilo-to-metric ton scale, batch uniformity matters. We know from experience one faulty batch doesn’t just mean rework—it can put customer deliverables or a clinical supply timeline in jeopardy.

Our specification for 3-[(1R,2S)-2-Amino-1-Hydroxypropyl]Phenol 2,3-Dihydroxybutanedioate focuses on high assay purity—topping 99% by HPLC—with chiral purity consistently verified by optical rotation and enantioselective chromatography. Particle size typically falls in the 100-300 micron range, supporting easy handling in both R&D reaction flasks and industrial blenders. Water content stays low by well-controlled vacuum drying, critical for avoiding unwanted hydrolysis or caking. We find value in running frequent Karl Fischer checks; less variance here means smoother blending, granulation, and reactivity when the product reaches the customer’s hands.

Color, an often overlooked attribute, matters for applications in analytical or color-sensitive formulations. Small color shifts can indicate issues in raw material quality or insufficient purification, so spectrophotometric monitoring runs alongside more traditional chemical analytics. We haven’t just shaped the product by these standards—we’ve changed purification protocols over time based on what customers and batch performance reports have told us.

Meeting Demands for Sustainability and Regulatory Assurance

With regulatory expectations rising and customer audits more frequent than ever, production has evolved. Plant managers now run environmental impact reviews, introduce green chemistry protocols, and select solvents that reconcile toxicity and process safety. Several years ago, customer audits triggered a shift towards recycling water streams and more robust containment procedures during salt formation.

It’s not just an exercise in paperwork; regular feedback loops—engineers working with operators and QA—drive process improvements, cut down on deviation events, and reduce waste. These changes echo down the entire value chain, impacting how downstream users view consistency, reliability, and regulatory fit.

Documentation standards require traceable batch records, ensuring not only reproducibility but also regulatory compliance. We’ve experienced firsthand how clients auditing supply chains increasingly ask for full traceability on chiral sources, solvent recovery ratios, and impurity profiles. By running our own process analytics, we ensure our clients avoid surprises during their own regulatory review—there’s nothing quite like the certainty that comes from hands-on control from flask to final drum.

Solving Challenges: From Bulk Handling to Applied Synthesis

Bulk volumes bring their own challenges—flow properties matter, as does bag-to-bag homogeneity. Several years of experience led us to implement additional anti-caking steps and employ various particle drying techniques, using both direct and indirect heat sources, depending on the season. Logistics teams learned that unanticipated humidity spikes could change the product’s behavior, prompting the introduction of barrier materials in shipment.

Customer formulations, especially in pilot production of active pharmaceutical ingredients or diagnostic agents, show that consistency in salt form and hydration keeps downstream process controls in spec. Rework or blending problems that crop up due to variable particle size or free moisture prompt us to revisit milling protocols. Feedback sessions between process control, R&D, and the customer-facing support team create an iterative loop, pushing the product towards greater uniformity in a way that can’t be managed by third-party resellers.

On the applied chemistry front, several case studies involve customers synthesizing beta-adrenergic agents or preparing advanced intermediates for clinical research. Reports from these partners underline that the tartrate salt’s solution behavior—clean, with minimal insoluble impurities—helped both in direct use and during downstream purification steps. We’ve adjusted our recrystallization solvents in response to specific solubility and filtration data, making iterative changes based on actual customer process bottlenecks.

Comparing to Alternatives: The Manufacturer’s Take

Plenty of similar phenolic amino alcohols exist, but many are delivered as racemates or in non-optimal salt forms. Differences on paper sometimes seem minor, but hands-on work tells another story.

The (1R,2S) configuration provides the specific activity profile that pharmacologists and synthetic chemists seek, while tartrate ensures both chemical and operational stability on the bench or in the reactor. On occasion, customers switch from a hydrochloride variant of the compound, hoping for better solubility or less hygroscopicity, only to find new challenges in stability or batch variance. Our experience shows that the tartrate salt offers a pragmatic middle ground: as stable as sulfonates but with improved water solubility, less irritating to handle, and fewer concerns over corrosivity compared to hydrochlorides.

We hear from polymer and resin developers as well, looking for a phenolic amino alcohol derivative that imparts UV stability or chemical resistance without introducing color impurities. The feedback loop here is clear: batches from our plant show fewer trace impurities per GC-MS analysis, and end-product color remains within the tightest acceptance windows.

Continuous Improvement from Direct Production Experience

No amount of catalog description replaces what direct manufacturing teaches. Years overseeing drying, bagging, and final product QC have taught us where variance creeps in and where the compound demonstrates resilience. Every time we run a batch, operator input, process chemist notes, and customer feedback converge into improvements—adjustments to filtration, drying regimes, or even how we train shipping crews on optimal palletization to avoid transit caking.

Routine investment in analytical equipment, such as new-generation chromatographs or near-infrared monitors, brings real gains in detection of trace impurities and confirmation of chiral purity. We validate every improvement by tying it to reduced off-spec rates or faster customer throughput.

Beyond the numbers, process consistency reassures our customers in ways that are hard to quantify but easy to appreciate when there’s no scramble for an emergency replacement batch. Pharmaceutical clients value not just purity but also documented reproducibility and transparent QA systems—needs we have learned to meet only through persistent experience, not aspirational claims.

Real-World Feedback Shaping Practices

Anecdotes from the field draw a line back to shop-floor experience. One pharmaceutical formulator reported problematic clumping with another manufacturer’s product under summer conditions—findings echoed by our own team when trialing imported samples. This feedback loop drives us to continually rethink our dehydration steps, updating both equipment calibration and the parameters on our own batch sheets. Another customer found alternate salt forms left them with off-flavors in pilot drug development, a concern we had already addressed in-house by refining our tartrate washing procedures and running expanded taste threshold evaluations.

Failure is as instructive as success. There have been headaches: a batch once left too long in final drying showed more than standard color drift, leading to a detailed root cause analysis, equipment tweaks, and stricter in-line monitoring. Only those who manufacture know the challenges in keeping every shipment within a narrow band of acceptability, and how direct action leads to better practice the next cycle.

The most valuable feedback is both honest and actionable. Feedback sessions rarely focus on fluff; they cut straight to what matters: solubility time, pH stability ranges, ease of filtration, and kinetics of downstream reactions. This level of insight, gained from a manufacturer’s perspective, is what has led to process optimizations that benefit every subsequent batch.

Future Directions in Manufacture and Application

Regulatory and performance demands evolve, and we’ve responded by integrating advanced process analytics and serialization throughout the value chain. There’s regular cross-talk between synthesis, packaging, and application support—integrating new data streams into both batch quality and resource efficiency. Upcoming process improvements focus on solvent recovery rates, real-time in-process checks for chiral drift, and expanded application testing for both standard and specialized end-users.

Emerging applications in green chemistry and sustainable pharmaceuticals prompt closer collaboration with downstream formulators and clinical R&D groups. These partnerships deepen our understanding of solubility profiles, interaction with excipients, and even sensory results in finished products—a holistic approach made possible by direct accountability for every kilo produced, stored, and shipped.

Concluding Perspective: The Advantage of Manufacturer Insight

There’s something unique gained by holding accountability for each step in production, from sourcing through to each customer’s application. Over the years, the lessons learned from both production challenges and customer successes continue to forge a compound that balances chemical performance, process reliability, and end-user satisfaction. This commentary draws from hands-on experience—a lifetime of daily observation and iteration—rather than distant speculation or marketing gloss.

3-[(1R,2S)-2-Amino-1-Hydroxypropyl]Phenol 2,3-Dihydroxybutanedioate (1:1) stands as the result of this applied expertise, informed by direct production oversight, iterative process improvement, and honest communication with the industries we serve. This perspective reveals what makes a compound more than just a chemical: it becomes a trusted workhorse, valued for tangible differences across the supply chain, through a lens only a true manufacturer can provide.